These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 31115212

  • 1. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X, Wu Y, Ji M, Zhang S.
    Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115212
    [Abstract] [Full Text] [Related]

  • 2. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W, Du X.
    PLoS One; 2012 May 01; 7(9):e44398. PubMed ID: 22970209
    [Abstract] [Full Text] [Related]

  • 3. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
    Luo X, Stock C, Burwinkel B, Brenner H.
    PLoS One; 2013 May 01; 8(5):e62880. PubMed ID: 23690963
    [Abstract] [Full Text] [Related]

  • 4. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X.
    Cancer; 2018 Feb 15; 124(4):785-796. PubMed ID: 29112225
    [Abstract] [Full Text] [Related]

  • 5. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A, Galandiuk S.
    Ann Surg; 2013 Sep 15; 258(3):400-8. PubMed ID: 24022433
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY, Chen CC, Chang YS, Tsai WS, You JF, Lin GP, Chen TW, Chen JS, Chan EC.
    Oncotarget; 2016 Mar 01; 7(9):10663-75. PubMed ID: 26848774
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
    Koga Y, Yamazaki N, Yamamoto Y, Yamamoto S, Saito N, Kakugawa Y, Otake Y, Matsumoto M, Matsumura Y.
    Cancer Epidemiol Biomarkers Prev; 2013 Oct 01; 22(10):1844-52. PubMed ID: 23950216
    [Abstract] [Full Text] [Related]

  • 9. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S, Moreno L, Augé JM, Serra-Burriel M, Cuatrecasas M, Moreira L, Martín A, Serradesanferm A, Pozo À, Costa R, Lacy A, Pellisé M, Lozano JJ, Gironella M, Castells A.
    Gastroenterology; 2020 Mar 01; 158(4):947-957.e4. PubMed ID: 31622624
    [Abstract] [Full Text] [Related]

  • 10. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.
    Oncol Rep; 2013 Jul 01; 30(1):320-6. PubMed ID: 23673725
    [Abstract] [Full Text] [Related]

  • 11. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W.
    Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY, Zhao XJ, Yu ZF, Hu FL, Liu YP, Cui BB, Dong XS, Zhao YS.
    Int J Clin Exp Pathol; 2015 Mar 01; 8(6):7092-101. PubMed ID: 26261602
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
    Yau TO, Wu CW, Tang CM, Chen Y, Fang J, Dong Y, Liang Q, Ng SS, Chan FK, Sung JJ, Yu J.
    Oncotarget; 2016 Jan 12; 7(2):1559-68. PubMed ID: 26621842
    [Abstract] [Full Text] [Related]

  • 15. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
    Chen JG, Cai J, Wu HL, Xu H, Zhang YX, Chen C, Wang Q, Xu J, Yuan XL.
    World J Gastroenterol; 2012 Jun 07; 18(21):2682-8. PubMed ID: 22690078
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.
    Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, Li J, Wang C.
    Br J Cancer; 2014 Nov 11; 111(10):1985-92. PubMed ID: 25233400
    [Abstract] [Full Text] [Related]

  • 18. Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening.
    Tao S, Haug U, Kuhn K, Brenner H.
    Br J Cancer; 2012 Apr 10; 106(8):1424-30. PubMed ID: 22454079
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma miRNA can detect colorectal cancer, but how early?
    Wikberg ML, Myte R, Palmqvist R, van Guelpen B, Ljuslinder I.
    Cancer Med; 2018 May 10; 7(5):1697-1705. PubMed ID: 29573205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.